Literature DB >> 19184110

Truncating loss-of-function mutations of DISP1 contribute to holoprosencephaly-like microform features in humans.

Erich Roessler1, Yong Ma, Maia V Ouspenskaia, Felicitas Lacbawan, Claude Bendavid, Christèle Dubourg, Philip A Beachy, Maximilian Muenke.   

Abstract

Defective function of the Sonic Hedgehog (SHH) signaling pathway is the most frequent alteration underlying holoprosencephaly (HPE) or its various clinical microforms. We performed an extensive mutational analysis of the entire human DISP1 gene, required for secretion of all hedgehog ligand(s) and which maps to the HPE 10 locus of human chromosome 1q41, as a HPE candidate gene. Here, we describe two independent families with truncating mutations in human DISP1 that resemble the cardinal craniofacial and neuro-developmental features of a recently described microdeletion syndrome that includes this gene; therefore, we suggest that DISP1 function contributes substantially to both of these signs in humans. While these clinical features are consistent with common HPE microforms, especially those linked to defective signaling by Sonic Hedgehog, we have insufficient evidence so far that functionally abnormal DISP1 alleles will commonly contribute to the more severe features of typical HPE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184110      PMCID: PMC2774849          DOI: 10.1007/s00439-009-0628-7

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  21 in total

Review 1.  Multiple hits during early embryonic development: digenic diseases and holoprosencephaly.

Authors:  Jeffrey E Ming; Maximilian Muenke
Journal:  Am J Hum Genet       Date:  2002-10-22       Impact factor: 11.025

Review 2.  Holoprosencephaly: new models, new insights.

Authors:  Robert S Krauss
Journal:  Expert Rev Mol Med       Date:  2007-09-24       Impact factor: 5.600

3.  Dispatched, a novel sterol-sensing domain protein dedicated to the release of cholesterol-modified hedgehog from signaling cells.

Authors:  R Burke; D Nellen; M Bellotto; E Hafen; K A Senti; B J Dickson; K Basler
Journal:  Cell       Date:  1999-12-23       Impact factor: 41.582

4.  The mutational spectrum of the sonic hedgehog gene in holoprosencephaly: SHH mutations cause a significant proportion of autosomal dominant holoprosencephaly.

Authors:  L Nanni; J E Ming; M Bocian; K Steinhaus; D W Bianchi; C Die-Smulders; A Giannotti; K Imaizumi; K L Jones; M D Campo; R A Martin; P Meinecke; M E Pierpont; N H Robin; I D Young; E Roessler; M Muenke
Journal:  Hum Mol Genet       Date:  1999-12       Impact factor: 6.150

5.  Mouse dispatched mutants fail to distribute hedgehog proteins and are defective in hedgehog signaling.

Authors:  Takatoshi Kawakami; T'Nay Kawcak; Ya-Jun Li; Wanhui Zhang; Yongmei Hu; Pao-Tien Chuang
Journal:  Development       Date:  2002-12       Impact factor: 6.868

6.  Hedgehog-mediated patterning of the mammalian embryo requires transporter-like function of dispatched.

Authors:  Yong Ma; Alfrun Erkner; Ruoyu Gong; Shenqin Yao; Jussi Taipale; Konrad Basler; Philip A Beachy
Journal:  Cell       Date:  2002-10-04       Impact factor: 41.582

Review 7.  Holoprosencephaly: clinical, anatomic, and molecular dimensions.

Authors:  M Michael Cohen
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2006-09

8.  Mutations in PATCHED-1, the receptor for SONIC HEDGEHOG, are associated with holoprosencephaly.

Authors:  Jeffrey E Ming; Michelle E Kaupas; Erich Roessler; Han G Brunner; Mahin Golabi; Mustafa Tekin; Robert F Stratton; Eva Sujansky; Sherri J Bale; Maximilian Muenke
Journal:  Hum Genet       Date:  2002-03-02       Impact factor: 4.132

9.  Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features.

Authors:  Erich Roessler; Yang-Zhu Du; Jose L Mullor; Esther Casas; William P Allen; Gabriele Gillessen-Kaesbach; Elizabeth R Roeder; Jeffrey E Ming; Ariel Ruiz i Altaba; Maximilian Muenke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-27       Impact factor: 11.205

10.  Inactivation of dispatched 1 by the chameleon mutation disrupts Hedgehog signalling in the zebrafish embryo.

Authors:  Y Nakano; H R Kim; A Kawakami; S Roy; A F Schier; P W Ingham
Journal:  Dev Biol       Date:  2004-05-15       Impact factor: 3.582

View more
  29 in total

1.  The unfolding clinical spectrum of holoprosencephaly due to mutations in SHH, ZIC2, SIX3 and TGIF genes.

Authors:  Aimée D C Paulussen; Constance T Schrander-Stumpel; Demis C J Tserpelis; Matteus K M Spee; Alexander P A Stegmann; Grazia M Mancini; Alice S Brooks; Margriet Collée; Anneke Maat-Kievit; Marleen E H Simon; Yolande van Bever; Irene Stolte-Dijkstra; Wilhelmina S Kerstjens-Frederikse; Johanna C Herkert; Anthonie J van Essen; Klaske D Lichtenbelt; Arie van Haeringen; Mei L Kwee; Augusta M A Lachmeijer; Gita M B Tan-Sindhunata; Merel C van Maarle; Yvonne H J M Arens; Eric E J G L Smeets; Christine E de Die-Smulders; John J M Engelen; Hubertus J Smeets; Jos Herbergs
Journal:  Eur J Hum Genet       Date:  2010-06-09       Impact factor: 4.246

2.  Utilizing prospective sequence analysis of SHH, ZIC2, SIX3 and TGIF in holoprosencephaly probands to describe the parameters limiting the observed frequency of mutant gene×gene interactions.

Authors:  Erich Roessler; Jorge I Vélez; Nan Zhou; Maximilian Muenke
Journal:  Mol Genet Metab       Date:  2012-01-12       Impact factor: 4.797

Review 3.  Genetics and signaling mechanisms of orofacial clefts.

Authors:  Kurt Reynolds; Shuwen Zhang; Bo Sun; Michael A Garland; Yu Ji; Chengji J Zhou
Journal:  Birth Defects Res       Date:  2020-07-15       Impact factor: 2.344

4.  Targeted panel sequencing establishes the implication of planar cell polarity pathway and involves new candidate genes in neural tube defect disorders.

Authors:  Marie Beaumont; Linda Akloul; Wilfrid Carré; Chloé Quélin; Hubert Journel; Laurent Pasquier; Mélanie Fradin; Sylvie Odent; Houda Hamdi-Rozé; Erwan Watrin; Valérie Dupé; Christèle Dubourg; Véronique David
Journal:  Hum Genet       Date:  2019-03-05       Impact factor: 4.132

5.  Clinical findings in patients with GLI2 mutations--phenotypic variability.

Authors:  C D P Bertolacini; L A Ribeiro-Bicudo; A Petrin; A Richieri-Costa; J C Murray
Journal:  Clin Genet       Date:  2011-01-19       Impact factor: 4.438

6.  NOTCH, a new signaling pathway implicated in holoprosencephaly.

Authors:  Valérie Dupé; Lucie Rochard; Sandra Mercier; Yann Le Pétillon; Isabelle Gicquel; Claude Bendavid; Georges Bourrouillou; Usha Kini; Christel Thauvin-Robinet; Timothy P Bohan; Sylvie Odent; Christèle Dubourg; Véronique David
Journal:  Hum Mol Genet       Date:  2010-12-31       Impact factor: 6.150

7.  The mutational spectrum of holoprosencephaly-associated changes within the SHH gene in humans predicts loss-of-function through either key structural alterations of the ligand or its altered synthesis.

Authors:  Erich Roessler; Kenia B El-Jaick; Christèle Dubourg; Jorge I Vélez; Benjamin D Solomon; Daniel E Pineda-Alvarez; Felicitas Lacbawan; Nan Zhou; Maia Ouspenskaia; Aimée Paulussen; Hubert J Smeets; Ute Hehr; Claude Bendavid; Sherri Bale; Sylvie Odent; Véronique David; Maximilian Muenke
Journal:  Hum Mutat       Date:  2009-10       Impact factor: 4.878

Review 8.  Extracephalic manifestations of nonchromosomal, nonsyndromic holoprosencephaly.

Authors:  Ariel F Martinez; Paul S Kruszka; Maximilian Muenke
Journal:  Am J Med Genet C Semin Med Genet       Date:  2018-05-15       Impact factor: 3.908

9.  Clinical characterization of individuals with deletions of genes in holoprosencephaly pathways by aCGH refines the phenotypic spectrum of HPE.

Authors:  Jill A Rosenfeld; Blake C Ballif; Donna M Martin; Arthur S Aylsworth; Bassem A Bejjani; Beth S Torchia; Lisa G Shaffer
Journal:  Hum Genet       Date:  2010-04       Impact factor: 4.132

10.  Zebrafish con/disp1 reveals multiple spatiotemporal requirements for Hedgehog-signaling in craniofacial development.

Authors:  Tyler Schwend; Sara C Ahlgren
Journal:  BMC Dev Biol       Date:  2009-11-30       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.